Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog
US6977247B2 · kind B2 · utility
0Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2002 |
| Grant date | Dec 20, 2005 |
| Priority date | — |
| Expiry date | Nov 5, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7072
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation, the method comprising: administering to the patient a 20(S)-camptothecin for a period of time during which a pyrimidine base analog is not being administered to the patient; and administering a pyrimidine base analog to the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.